Company Information
USD
1.63
- (-4.1%)
NASDAQ:VANI, VIVANI MEDICAL INC
Industry: Biotechnology
End of Day: 26 April 2024 GMT-4
Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.
Address
5858 Horton Street
Suite 280
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Daniel M. Bradbury
Director
Ms. Brigid A. Makes
CFO/Chief Accounting Officer
Dr. Lisa E. Porter, M.D.
Chief Medical Officer
Mr. Gregg G. Williams
Chairman of the Board/Director
Mr. Aaron Mendelsohn, J.D.
Director
Dr. W. Dean Baker, PhD
Director
Ms. Alexandra Larson, J.D.
Director
Dr. Adam Mendelsohn, PhD
CEO/Director
Mr. Truc Le, M.B.A.
COO
Mr. Donald Dwyer, M.B.A.
Other Executive Officer
Ownership
Institution Holdings
Tanager Wealth Management LLP
1,651,222 (3.236%)
Vanguard Group Inc
452,100 (0.886%)
Commonwealth Equity Services Inc
360,530 (0.706%)
Monetary Management Group Inc
304,977 (0.598%)
Vanguard Investments Australia Ltd
264,612 (0.519%)
Geode Capital Management, LLC
197,141 (0.386%)
Fidelity Management & Research Company LLC
185,426 (0.363%)
Glassman Wealth Services
140,385 (0.275%)
EVOKE WEALTH, LLC
134,870 (0.264%)
BlackRock Inc
57,206 (0.112%)
Funds Holdings
Vanguard US Total Market Shares ETF
264,612 (0.519%)
Vanguard Total Stock Market Index Fund
264,612 (0.519%)
iShares Micro-Cap ETF
50,959 (0.100%)
Fidelity Series Total Market Index Fund
21,575 (0.042%)
NT Ext Equity Mkt Idx Fd - DC - NL
4,584 (0.009%)
BNYM Mellon SL Market Completion Fund
876 (0.002%)
BlackRock Extended Equity Market
425 (0.001%)
SSgA U.S. Total Market Index Fund
249 (0.000%)
NT Ext Equity Mkt Indx Fd DC Lending
185 (0.000%)
Extended Equity Market Fund M
53 (0.000%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
